Development of Hemolytic Anemia in a Nivolumab-Treated Patient with Refractory Metastatic Squamous Cell Skin Cancer and Chronic Lymphatic Leukemia

Case Reports in Oncology

Volumn 9, Issue 2, 2016, Pages 373-378

  Schwab, K S ^a   Heine, A ^a   Weimann, T ^b   Kristiansen, G ^a   Brossart, P ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b Betaklinik Bonn   (Germany)

Author keywords

Hemolysis; Nivolumab; Squamous cell carcinoma

Indexed keywords

ANTIBODY; CETUXIMAB; CISPLATIN; COMPLEMENT COMPONENT C3; CYCLOPHOSPHAMIDE; DOCETAXEL; FLUDARABINE; HEMOGLOBIN; IBRUTINIB; IMMUNOGLOBULIN G; NIVOLUMAB; PREDNISOLONE; PROGRAMMED DEATH 1 RECEPTOR; RITUXIMAB;

AGED; AGGLUTINATION TEST; ARTICLE; AUTOIMMUNE DISEASE; BLOOD CELL COUNT; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CASE REPORT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHRONIC LYMPHATIC LEUKEMIA; CHRONOPHARMACOLOGY; CORTICOSTEROID THERAPY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FACE DISORDER; FATIGUE; GENERALIZED LYMPHADENOPATHY; HEMOLYTIC ANEMIA; HUMAN; INFECTION; LEUKEMIA REMISSION; LUNG TUMOR; LYMPHOCYTE COUNT; LYMPHOMA; MALE; MEDIASTINUM TUMOR; MULTIPLE CYCLE TREATMENT; MUSCLE WEAKNESS; PARESTHESIA; PRIORITY JOURNAL; SALVAGE THERAPY; SIDE EFFECT; SKIN CARCINOMA; SPLENOMEGALY; SWELLING; THROMBOCYTE COUNT; TREATMENT DURATION; TREATMENT RESPONSE; VERY ELDERLY;

EID: 84976526097     PISSN: None     EISSN: 16626575     Source Type: Journal    
DOI: 10.1159/000447508     Document Type: Article

References (15)

1. DeConti RC: Chemotherapy of squamous cell carcinoma of the skin. Semin Oncol 2012;39:145-149
2. Samarasinghe V, Madan V, Lear JT: Management of high-risk squamous cell carcinoma of the skin. Expert Rev Anticancer Ther 2011;11:763-769
3. Brewster AM, Lee JJ, Clayman GL, et al: Randomized trial of adjuvant 13-cis-retinoic acid and interferon alfa for patients with aggressive skin squamous cell carcinoma. J Clin Oncol 2007;25:1974-1978
4. Lippman SM, Parkinson DR, Itri LM, et al: 13-cis-retinoic acid and interferon alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skin. J Natl Cancer Inst 1992;84:235-241
5. Shin DM, Glisson BS, Khuri FR, et al: Phase II and biologic study of interferon alfa, retinoic acid, and cisplatin in advanced squamous skin cancer. J Clin Oncol 2002;20:364-370
6. Cartei G, Cartei F, Interlandi G, et al: Oral 5-fluorouracil in squamous cell carcinoma of the skin in the aged. J Clin Oncol 2000;23:181-184
7. Princeton NJ: CheckMate-141, a pivotal phase 3 Opdivo (nivolumab) head and neck cancer trial, stopped early (news release). Bristol-Myers Squibb, January 28, 2016. http://news.bms.com/press-release/checkmate-141-pivotal-phase-3-opdivo-nivolumab-head-and-neck-cancer-trial-stopped-earl. Accessed January 29, 2016
8. Borradori L, Sutton B, Shayesteh P, Daniels GA: Rescue therapy with anti-programmed cell death protein 1 inhibitors (PD-1) of advanced cutaneous squamous cell carcinoma and basosquamous carcinoma: preliminary experience in 5 cases. Br J Dermatol 2016, DOI: 10.1111/bjd.14642
9. Stratigos A, Garbe C, Lebbe C, Malvehy J, del Marmol V, Pehamberger H, Peris K, Becker JC, Zalaudek I, Saiag P, Middleton MR, Bastholt L, Testori A, Grob JJ; European Dermatology Forum (EDF); European Association of Dermato-Oncology (EADO); European Organization for Research and Treatment of Cancer (EORTC): Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline. Eur J Cancer 2015;51:1989-2007
10. Swiecicki PL, Malloy KM, Worden FP: Advanced oropharyngeal squamous cell carcinoma: pathogenesis, treatment, and novel therapeutic approaches. World J Clin Oncol 2016;7:15-26
11. Sacco AG, Cohen EE: Current treatment options for recurrent or metastatic head and neck squamous cell carcinoma. J Clin Oncol 2015;33:3305-3313
12. Cranmer LD, Engelhardt C, Morgan SS: Treatment of unresectable and metastatic cutaneous squamous cell carcinoma. Oncologist 2010;15:1320-1328
13. Kong BY, Micklethwaite KP, Swaminathan S, Kefford RF, Carlino MS: Autoimmune hemolytic anemia induced by anti-PD-1 therapy in metastatic melanoma. Melanoma Res 2016;26:202-204
14. Garbe E, Andersohn F, Bronder E, et al: Drug induced immune haemolytic anaemia in the Berlin Case-Control Surveillance Study. Br J Haematol 2011;154:644
15. Mayer B, Bartolmäs T, Yürek S, Salama A: Variability of findings in drug-induced immune haemolytic anaemia: experience over 20 years in a single centre. Transfus Med Hemother 2015;42:333.